Since the Social Security Institute does not have stock of some oncological drugs, the health portfolio will provide drugs while the IPS replenishment processes last.
Through articulated management between the Ministry of Health, through National Cancer Institute – INCAN, and the Social Security Institute medicine is guaranteed to oncology patients who are insured by the pension, which with stock zero some drugs while the The bidding process for the purchase is over and the lot will be received between the months of October and November.
she dr. Raúl Doria, director of INCAN, He stressed that patients cannot wait long to continue their treatments, so the payment process for services between the two institutions is activated. The drugs provided by Public Health in IPS are Cetuximab and Fulvestran, as detailed by the director of this special center of the Ministry of Health.
The current administration of INCAN, since its inauguration, is dedicated to managing the resupply of oncology drugs that have been in short supply for months which prevents many patients from continuing their treatments in a timely manner.
In that sense, from the first week of administration, INCAN chief meets with patient associations and providers to find immediate solution of the need he found upon entering the institution. In this way, most of the missing items have been filled again, except for Cisplatin and Palbociclib, which are not available in the market because the companies given the call do not have these products for delivery.
“We have many options to reduce the shortage of medicines and ensure that no one is left without their treatment. I am committed to continue to find solutions for all patients, because they deserve our maximum effort to give them a timely response. Time is precious“, said Dr. Raúl Doria.
